SILVER COMPLEX–CATALYZED CYCLIZATION
3235
J ¼ 1.6, 1H), 7.48 (d, J ¼ 0.7 Hz, 1H), 7.42 (t, J ¼ 7.6 Hz, 2H), 7.28 (m, 1H), 6.06 (s,
1H), 5.84 (d, J ¼ 9.3 Hz, 1H), 2.20 (d, J ¼ 9.7 Hz, 1H), 1.35 (s, 9H); 13C NMR
(CDCl3, 100 MHz, ppm) d 156.3, 153.0, 148.1, 134.1, 130.7, 128.9, 128.6, 127.9,
127.0, 121.5, 106.9, 102.7, 73.5, 34.8, 31.5.
(Z)-2-Benzylidene-7-nitro-5-tert-butyl-2,3-dihydrobenzofuran-3-ol (2i).
IR (KBr): nmax 3515, 2960, 2870, 1633, 1542, 1327, 1224, 1096, 1040, 895 cmꢃ1
;
1H NMR (CDCl3, 400 MHz, ppm) d 8.16 (s, 1H), 7.86–7.85 (m, 3H), 7.44 (t,
J ¼ 7.4 Hz, 2H), 7.32–7.27 (m, 1H), 6.15 (s, 1H), 5.84 (d, J ¼ 9.0 Hz, 1H), 2.34 (d,
J ¼ 9.5 Hz, 1H), 1.39 (s, 9H); 13C NMR (CDCl3, 100 MHz, ppm) d 155.8, 149.8,
147.2, 133.4, 132.2, 129.3, 129.1, 128.8, 127.7, 122.8, 108.7, 71.4, 35.0; GC=MS
m=z (%) 325 (Mþ, 100), 324, 308, 278, 248, 206, 188, 132, 105, 77; HRMS calcd.
for C19H19NO4: 325.1314; found: 325.1316.
(Z)-2-(4-Chlorobenzylidene)-2,3-dihydrobenzofuran-3-ol
(2j).[7] IR
(KBr): nmax 3331, 2923, 1684, 1615, 1600, 1466, 1292, 1237, 1134, 1085, 1018,
910 cmꢃ1; 1H NMR (400 MHz, CDCl3) d 7.67 (d, J ¼ 8.5 Hz, 2H), 7.52 (d, J ¼ 7.2 Hz,
1H), 7.37–7.35 (m, 3H), 7.12 (t, J ¼ 7.6 Hz, 2H), 5.98 (s, 1H), 5.78 (d, J ¼ 6.9 Hz, 1H),
2.21 (d, J ¼ 8.5 Hz, 1H); 13C NMR (75 MHz, CDCl3) 157.6, 157.5, 133.1, 132.4,
130.8, 130.0, 128.7, 125.7, 123.1, 110.7, 104.9, 72.6.
Z)-2-(4-Methylbenzylidene)-2,3-dihydrobenzofuran-3-ol
(2k).[7] IR
(KBr): nmax 3387, 3052, 2921, 1688, 1603, 1479, 1467, 1291, 1234, 1134, 1132,
1085, 1010, 906 cmꢃ1
;
1H NMR (CDCl3, 400 MHz, ppm) d 7.64 (d, J ¼ 8.1 Hz,
2H), 7.51 (d, J ¼ 7.2, 1H), 7.36 (dd, J ¼ 0.9, 7.6 Hz, 1H), 7.21 (d, J ¼ 7.9 Hz, 2H),
7.12–7.08 (m, 2H), 6.00 (s, 1H), 5.76 (bs, 1H), 2.39 (s, 3H), 2.20 (bs, 1H); 13C
NMR (CDCl3, 100 MHz, ppm) d 157.8, 156.3, 136.7, 131.7, 130.6, 129.2, 128.6,
127.0, 125.7, 122.8, 110.6, 106.0, 72.5, 21.3.
(Z)-5-Bromo-2-(4-methylbenzylidene)-2,3-dihydrobenzofuran-3-ol (2 l).[7]
IR (KBr): nmax 3423, 3027, 1689, 1607, 1512, 1471, 1236, 1096, 1005, 906 cmꢃ1; 1H
NMR (CDCl3, 400 MHz, ppm) d 7.61–7.58 (m, 3H), 7.46 (dd, J ¼ 1.6, 8.5 Hz, 1H),
7.20 (d, J ¼ 7.9 Hz, 2H), 6.98 (d, J ¼ 8.5 Hz, 1H), 6.00 (s, 1H), 5.74 (s, 1H), 2.38 (s,
3H), 2.24 (bs, 1H); 13C NMR (CDCl3, 100 MHz, ppm) d 156.8, 155.8, 137.0, 133.4,
131.2, 129.2, 128.8, 128.7, 114.8, 112.3, 106.6, 72.2, 21.3.
(Z)-2-(4-Methoxybenzylidene)-2,3-dihydrobenzofuran-3-ol (2m)[6]. IR
(KBr): nmax 3369, 3043, 2997, 2929, 2837, 1685, 1607, 1514, 1462, 1294, 1253,
1
1179, 1130, 1084 cmꢃ1; H NMR (CDCl3, 300 MHz, ppm) d 7.66 (d, J ¼ 8.7 Hz,
2H), 7.49 (d, J ¼ 7.2 Hz, 1H), 7.33 (t, J ¼ 7.8 Hz, 1H), 7.11–7.06 (m, 2H), 6.92 (d,
J ¼ 8.7 Hz, 1H), 5.95 (bs, 1H), 5.74 (d, J ¼ 9.3 Hz, 1H), 3.83 (s, 3H), 2.18 (d,
J ¼ 9.3 Hz, 1H); 13C NMR (CDCl3, 75 MHz, ppm) d 158.6, 157.9, 155.5, 130.7,
130.1, 127.5, 127.2, 125.8, 122.9, 114.1, 110.7, 105.8, 72.6, 55.4.
(Z)-5-Bromo-2-(4-methoxybenzylidene)-2,3-dihydrobenzofuran-3-ol (2n).
IR (KBr): nmax 3354, 3080, 2957, 2836, 1604, 1512, 1471, 1253, 1180, 1095, 1024,
1
904 cmꢃ1; H NMR (CDCl3, 300 MHz, ppm) d 7.64–7.59 (m, 2H), 7.45–7.414 (m,
2H), 6.96–6.89 (m, 2H), 5.95 (s, 1H), 5.72 (d, J ¼ 9.0 Hz, 1H), 3.83 (s, 3H), 2.31
(d, J ¼ 9.6 Hz, 1H); 13C NMR (CDCl3, 75 MHz, ppm) d 158.8, 157.0, 155.0, 133.5,
130.2, 129.5, 129.0, 127.0, 114.9, 114.2, 112.4, 106.4, 72.2, 55.4; MS (EI) m=z (%)